Diseases, Conditions, Syndromes

Protein molecule may improve survival in deadly lung disease

Researchers at the University of Illinois at Chicago College of Medicine have discovered a protein molecule that seems to slow the progression of pulmonary fibrosis, a progressive lung disease that is often fatal three to ...

Diseases, Conditions, Syndromes

Increased risk of carotid artery wall thickening in COPD

(HealthDay)—For older adults with chronic obstructive pulmonary disease (COPD), the likelihood of carotid artery thickening is increased and vulnerable lipid core plaques are more frequent than in controls with normal lung ...

Diseases, Conditions, Syndromes

Small reduction in lung function with Tx de-escalation in COPD

(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients with chronic obstructive pulmonary disease (COPD) but ...

Cardiology

COPD tied to increased risk of ischemic, hemorrhagic stroke

(HealthDay)—Chronic obstructive pulmonary disease (COPD) is associated with increased risk of all stroke, ischemic stroke, and hemorrhagic stroke, although the risks are attenuated after adjustment for smoking, according ...

Diseases, Conditions, Syndromes

Considerable health care system burden for undiagnosed COPD

(HealthDay)—The overall health system burden of exacerbations in patients with undiagnosed chronic obstructive pulmonary disease (COPD) is considerable, according to a study published in the Aug. 1 issue of the American ...

Diseases, Conditions, Syndromes

Once-daily triple-Tx improves lung function, HRQoL in COPD

(HealthDay)—For patients with chronic obstructive pulmonary disease (COPD), once-daily single-inhaler triple therapy is better for lung function and health-related quality of life than inhaled corticosteroid (ICS)/long-acting ...

page 5 from 11